This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignee: Universitè Laval. Active years: 2009-2012.
Location History:
- Lac St-Charles, CA (2009)
- Québec, CA (2009 - 2012)
Company Filing History:
Years Active: 2009-2012
Title: The Innovative Contributions of Karen Vandal
Introduction
Karen Vandal is a prominent inventor based in Québec, Canada. She has made significant contributions to the field of medical research, particularly in the treatment of inflammatory diseases. With a total of 3 patents, her work focuses on innovative methods to address complex health issues.
Latest Patents
One of her latest patents is a method for treating rheumatoid arthritis using an anti-S100A9 antibody. This invention relates to compounds and methods for modulating, reducing, or inhibiting inflammatory reactions in patients. The targeted inflammatory reactions include cell migration, secretion of toxic products, and proteolysis at sites of inflammation. The reduction of these manifestations occurs through the use of an anti-S100 polynucleotide or polypeptide inhibitor or antagonist, aimed at S100A8, S100A9, or S100A12, either alone or in combination with other inhibitors of chemokines or immune-modulating products.
Another notable patent involves the use of S100 protein as a neutrophil activator for alleviating neutropenia in cancer treatment. This invention describes a method and composition for inducing lymphocyte proliferation and migration, as well as reducing the risks of microbial infections in immuno-suppressed patients. Specifically, it utilizes S100 proteins, such as MRP, to induce the proliferation, differentiation, and release of immune cells from bone marrow, particularly in patients with lowered neutrophil blood concentrations.
Career Highlights
Karen Vandal is affiliated with Université Laval, where she conducts her research and develops her innovative solutions. Her work has garnered attention for its potential impact on treating serious health conditions.
Collaborations
She collaborates with notable colleagues, including Philippe A Tessier and Pascal Rouleau, to advance her research and explore new avenues in medical science.
Conclusion
Karen Vandal's contributions to medical research through her patents demonstrate her commitment to innovation in healthcare. Her work not only addresses pressing medical challenges but also paves the way for future advancements in treatment methodologies.